cadenas

ITCC-052 CARFILZOMIB

  • Innovative Therapies
    for Children with Cancer in Europe
  • Contact us

ITCC-052 CARFILZOMIB

Phase 1b/2 Study of Carfilzomib in combination with Dexamethasone, Mitoxantrone, PEG-asparaginase, and Vincristine (R3 Induction Backbone) in pediatric subjects with relapsed or refractory Acute Lymphoblastic Leukemia

Promotor Name : Amgen

Investigator Name : A. BARUCHEL

Trial registered on clinicaltrials.gov: NCT02303821